Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Galenica AG ( (CH:GALE) ).
Galenica AG reported robust growth in 2024, with a 4.7% increase in sales and a 10.3% rise in adjusted EBIT, surpassing market growth and gaining market share. The company plans to continue expanding its healthcare services and digital solutions in 2025, aiming for sustainable growth and enhanced patient care, which could strengthen its market position and benefit stakeholders.
More about Galenica AG
Galenica AG operates in the healthcare industry, focusing on pharmaceutical care and health services. It offers a range of products and services, including pharmacy networks, health services, logistics, and IT solutions, with a strong market presence in Switzerland.
YTD Price Performance: 10.09%
Average Trading Volume: 87,932
Current Market Cap: CHF4.05B
Find detailed analytics on GALE stock on TipRanks’ Stock Analysis page.